GLP-1 receptor signaling: effects on pancreatic β-cell proliferation and survival

Diabetes and Metabolism

Volumn 34, Issue SUPPL. 2, 2008, Pages

  Buteau, J ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

cell mass; Apoptosis; Dipeptidyl peptidase IV; Glucagon like peptide 1; Incretins

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 3BETA; INSULIN; TRANSCRIPTION FACTOR PDX 1;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VOLUME; DIABETES MELLITUS; GENE; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HORMONE RECEPTOR INTERACTION; HUMAN; INSULIN GENE; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS FUNCTION DISORDER; PANCREAS ISLET BETA CELL;

ANTIGENS, CD26; CELL DIVISION; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN-SECRETING CELLS; PROTEASE INHIBITORS; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

EID: 47149103321     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(08)73398-6     Document Type: Article

References (43)

1. Zimmet P.Z., and Alberti kg. Introduction : Globalization and the noncommunicable disease epidemic. Obesity (Silver Spring) 14 (2006) 1-3
2. Zimmet P., Alberti kg., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
3. Weir G.C., and Bonner-Weir S. Five stages of evolving Beta-cell dysfunction during progression to diabetes. Diabetes 53 Suppl 3 (2004) S16-S21
4. Donath M.Y., Storling J., Mædler K., et al. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81 (2003) 455-470
5. Butler A.E., Janson J., Bonner-Weir S., et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 (2003) 102-110
6. Mathis D., Vence L., and Benoist C. beta-Cell death during progression to diabetes. Nature 414 (2001) 792-798
7. Moller D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414 (2001) 821-827
8. Drucker D.J. The biology of incretin hormones. Cell Metab 3 (2006) 153-165
9. Drucker D.J. Minireview : the glucagon-like peptides. Endocrinology 142 (2001) 521-527
10. Holst J.J., and Orskov C. The incretin approach for diabetes treatment : modulation of islet hormone release by GLP-1 agonism. Diabetes 53 Suppl 3 (2004) S197-S204
11. Gutniak M., Orskov C., Holst J.J., et al. Antidiabetogenic effect of glucagons-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326 (1992) 1316-1322
12. Nauck M.A., Heimesaat mm., Orskov C., et al. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91 (1993) 301-307
13. Kreymann B., Williams G., Ghatei M.A., et al. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2 (1987) 1300-1304
14. Holst J.J., and Deacon C.F. Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. Curr Opin Pharmacol 4 (2004) 589-596
15. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89 (1992) 8641-8645
16. Thorens B., Porret A., Buhler L., et al. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin- (9-39) an antagonist of the receptor. Diabetes 42 (1993) 1678-1682
17. Brubaker P.L., and Drucker D.J. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels 8 (2002) 179-188
18. Holz G.G., Leech C.A., and Habener J.F. Activation of a cAMP-regulated Ca (2+) -signaling pathway in pancreatic beta-cells by the insulinotropic hormone glucagon-like peptide-1. J Biol Chem 270 (1995) 17749-17757
19. Kang G., and Chepurny O.G. Holz GG. cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+ -induced Ca2+ release in INS-1 pancreatic beta-cells. J Physiol 536 (2001) 375-385
20. Gromada J., Bokvist K., Ding W.G., et al. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 47 (1998) 57-65
21. Buteau J., Foisy S., Joly E., et al. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52 (2003) 124-132
22. Buteau J., Roduit R., Susini S., et al. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1) -cells. Diabetologia 42 (1999) 856-864
23. Buteau J., Foisy S., Rhodes C.J., et al. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes 50 (2001) 2237-2243
24. Buteau J., El-Assaad W., Rhodes C.J., et al. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia 47 (2004) 806-815
25. Trumper K., Trumper A., Trusheim H., et al. Integrative mitogenic role of protein kinase B/Akt in beta-cells. Ann N Y Acad Sci 921 (2000) 242-250
26. Hui H., Nourparvar A., Zhao X., et al. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3- kinase-dependent pathway. Endocrinology 144 (2003) 1444-1455
27. Wang Q., Li L., Xu E., et al. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia 47 (2004) 478-487
28. Fehmann H.C., and Habener J.F. Insulinotropic hormone glucagons-like peptide-I (7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells. Endocrinology 130 (1992) 159-166
29. Stoffers D.A., Kieffer T.J., Hussain M.A., et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49 (2000) 741-748
30. Holz G.Gt., Kuhtreiber W.M., and Habener J.F. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7-37). Nature 361 (1993) 362-365
31. Park S., Dong X., Fisher T.L., et al. Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. J Biol Chem 281 (2006) 1159-1168
32. Jhala U.S., Canettieri G., Screaton R.A., et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17 (2003) 1575-1580
33. Buteau J., Spatz ml., and Accili D. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass. Diabetes 55 (2006) 1190-1196
34. Buteau J., Shlien A., Foisy S., et al. Metabolic diapause in pancreatic betacells expressing a gain-of-function mutant of the forkhead protein Foxo1. J Biol Chem 282 (2007) 287-293
35. Kitamura T., Nakae J., Kitamura Y., et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110 (2002) 1839-1847
36. Li Y., Cao X., Li L.X., et al. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Diabetes 54 (2005) 482-491
37. Wang Q., and Brubaker P.L. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia 45 (2002) 1263-1273
38. Farilla L., Hui H., Bertolotto C., et al. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143 (2002) 4397-4408
39. Li Y., Hansotia T., Yusta B., et al. Glucagon-like Peptide-1 Receptor Signaling Modulates beta Cell Apoptosis. J Biol Chem 278 (2003) 471-478
40. Yusta B., Baggio L.L., Estall J.L., et al. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab 4 (2006) 391-406
41. Tsunekawa S., Yamamoto N., Tsukamoto K., et al. Protection of pancreatic{beta}-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies. J Endocrinol 193 (2007) 65-74
42. Reimer M.K., Holst J.J., and Ahren B. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice. Eur J Endocrinol 146 (2002) 717-727
43. Pospisilik J.A., Martin J., Doty T., et al. Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats. Diabetes 52 (2003) 741-750